Drug Vial Label: Zilretta¿ recall
Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira…
Why was Drug Vial Label: Zilretta¿ recalled?
Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 082657 (kit 23-9004), Exp: July 2024.
- Product
- Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira…
- Recalling firm
- PACIRA PHARMACEUTICALS INC
- Quantity
- 43,768 kits
- Distribution
- U.S. Nationwide.
- Recall date
- June 19, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)